EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Xiaoqinglong decoction mitigates nasal inflammation and modulates gut microbiota in allergic rhinitis mice

Hao-Lan Liu, Hui-Fang Chen, Yun-Dang Wu, Ya-Jie Yan, Xue-Cheng He, Zhong-Zheng Li, Yan Ruan, Gan-Long Wu

Frontiers in Microbiology · 15.05.2024 · 15

DOI: 10.3389/fmicb.2024.1290985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 15.05.2024. Verfasst von Hao-Lan Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Jishou University, Jishou, China. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Allergic rhinitis (AR) is a respiratory immune system disorder characterized by dysregulation of immune responses. Within the context of AR, gut microbiota and its metabolites have been identified as contributors to immune modulation. These microorganisms intricately connect the respiratory and gut immune systems, forming what is commonly referred to as the gut-lung axis. Xiaoqinglong Decoction (XQLD), a traditional Chinese herbal remedy, is widely utilized in traditional Chinese medicine for the clinical treatment of AR. In this study, it is hypothesized that the restoration of symbiotic microbiota balance within the gut-lung axis plays a pivotal role in supporting the superior long-term efficacy of XQLD in AR therapy. Therefore, the primary objective of this research is to investigate the impact of XQLD on the composition and functionality of the gut microbiota in a murine model of AR.

Methods

An ovalbumin-sensitized mouse model to simulate AR was utilized, the improvement of AR symptoms after medication was investigated, and high-throughput sequencing was employed to analyze the gut microbiota composition.

Results

XQLD exhibited substantial therapeutic effects in AR mice, notably characterized by a significant reduction in allergic inflammatory responses, considerable alleviation of nasal symptoms, and the restoration of normal nasal function. Additionally, following XQLD treatment, the disrupted gut microbiota in AR mice displayed a tendency toward restoration, showing significant differences compared to the Western medicine (loratadine) group.

Discussion

This results revealed that XQLD may enhance AR allergic inflammatory responses through the regulation of intestinal microbiota dysbiosis in mice, thus influencing the dynamics of the gut-lung axis. The proposal of this mechanism provides a foundation for future research in this area.

Schlagwörter

Stichwörter der Autor:innen

Xiaoqinglong decoctionallergic rhinitisgut microbiotagut-lung axistype 2 inflammation

Autor:innen und Institutionen

  • School of Medicine, Jishou University, Jishou, China.
  • Department of Otolaryngology Head and Neck Surgery, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Lingnan Institute of Otolaryngology, Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou, China.
  • Department of Medicine, Guangxi University of Science and Technology, Liuzhou, China.
  • National-Regional Joint Engineering Research Center for Soil Pollution Control and Remediation in South China, Guangzhou, China.
  • Guangdong Key Laboratory of Integrated Agro-environmental Pollution Control and Management, Institute of Eco-environmental and Soil Sciences, Guangdong Academy of Sciences, Guangzhou, China.

Zitieren

APA

Liu, H. L., Chen, H. F., Wu, Y. D., Yan, Y. J., He, X. C., Li, Z. Z., Ruan, Y., & Wu, G. L. (2024). Xiaoqinglong decoction mitigates nasal inflammation and modulates gut microbiota in allergic rhinitis mice. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1290985

Vancouver

Liu HL, Chen HF, Wu YD, Yan YJ, He XC, Li ZZ, et al. Xiaoqinglong decoction mitigates nasal inflammation and modulates gut microbiota in allergic rhinitis mice. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1290985

BibTeX
@article{Liu2024,
  author = {Liu, Hao-Lan and Chen, Hui-Fang and Wu, Yun-Dang and Yan, Ya-Jie and He, Xue-Cheng and Li, Zhong-Zheng and Ruan, Yan and Wu, Gan-Long},
  title = {Xiaoqinglong decoction mitigates nasal inflammation and modulates gut microbiota in allergic rhinitis mice},
  journal = {Frontiers in Microbiology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fmicb.2024.1290985}
}
Kostenlos starten →